ELVITEGRAVIR | ELVITEGRAVIR | ATC J05AR09 ATC J05AX11 ATC J05AR18
ANTIINFECTIVES TREATMENT OF HIV-1 INFECTION INHIBITOR | ORAL | Cmax 3.8 MICROMOLAR Tmax 4 HOUR PPB 98 PERCENT HT 12.9 HOUR SOLUBILITY LESS THAN 0.3 MICROGRAMS PER ML IN WATER | VIRAL INTEGRASE PDB 3L2U (CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS (PFV) INTASOME IN COMPLEX WITH MAGNESIUM AND GS9137 (ELVITEGRAVIR)) LIGAND CODE = ELV (link to the list of PDB complexes) Download experimental 3D coordinates of ELV with added hydrogens | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE INHIBITOR CHEMBL3471 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE Q7ZJM1 INTEGRASE HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME HYDROLASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |